Medspa Advertising & Claims Compliance Guide (FTC)

Every claim about a product's efficacy must be backed by competent and reliable scientific evidence obtained before the claim is made. The FTC defines this as evidence that would be considered adequate by qualified experts in the relevant field. For aesthetic products and devices, this typically means clinical studies, peer-reviewed publications, or manufacturer data from FDA submissions (510(k) summaries, PMA approvals, or cleared indications).

Claims fall into two categories: express claims (explicit statements: "reduces wrinkles by 50%") and implied claims (suggested by images, testimonials, or context). Both require substantiation. A common violation: claiming a device "lifts" skin when the FDA clearance only covers "skin tightening" or "collagen remodeling." Stick to the cleared indication. If you make a claim beyond the device's FDA clearance, you're making an unapproved drug or device claim, which triggers FDA and FTC enforcement simultaneously.

Before/after images are the most powerful—and most regulated—marketing tool in aesthetics. The FTC requires that photos be:

• Representative of typical results. You cannot cherry-pick the best outcome and imply it's typical. If you show one result, you must disclose that it may not be typical; better practice is to show a range or state the percentage of patients who achieved that result.
• Unaltered. No filters, Photoshop, or color correction beyond standard photography adjustments (exposure, contrast). Any material alteration must be disclosed.
• Taken under consistent conditions. Same lighting, angle, distance, and timing (e.g., "photos taken 2 weeks post-treatment"). Inconsistent conditions mislead about actual results.
• Accompanied by material disclosures. If results depend on multiple treatments, ongoing maintenance, or concurrent products, say so. Example: "Results shown after 3 sessions, 4 weeks apart, with daily sunscreen use."

Testimonials paired with before/after images must also comply: the person in the photo must be the person giving the testimonial, and results must be typical or clearly labeled as exceptional.

Under the FTC Endorsement Guides, testimonials must reflect the typical experience of customers, not cherry-picked outliers. If you feature a patient saying "My skin looks 20 years younger," you must have evidence that this is a representative result, not a one-in-a-thousand outcome.

Influencer and staff endorsements carry extra weight: if your nurse injector posts a before/after of a patient on Instagram, that's an endorsement. The endorser must disclose any material connection (employment, compensation, free product). A simple hashtag like #ad or #sponsored is required; burying it in a caption is insufficient.

Comparative claims ("better than Botox," "outperforms competitors") require head-to-head clinical evidence. Avoid them unless you have published comparative studies. Claims like "the most advanced" or "the only" device that does X are superlatives that must be substantiated or they're deceptive.

The FTC and FDA share enforcement authority over aesthetic marketing. A claim that crosses into drug territory triggers FDA scrutiny:

• Device claims (legal if substantiated): "Stimulates collagen production," "tightens skin," "reduces the appearance of wrinkles."
• Drug claims (unapproved): "Treats wrinkles," "cures acne," "reverses aging." These imply a therapeutic effect and require FDA drug approval.

Similarly, claiming a filler "restores lost volume" is fine; claiming it "treats facial aging disorder" is a drug claim. Neurotoxin marketing must avoid "treats" language; use "reduces the appearance of" or "smooths."

If your marketing crosses into unapproved drug or device claims, the FDA can issue a warning letter, seize products, or pursue criminal charges. The FTC will simultaneously pursue unfair/deceptive practices. Coordinate with your compliance counsel and manufacturer to ensure all claims align with FDA-cleared indications.

Overstated results: Claiming "permanent" results for a temporary product (neurotoxin lasts 3–4 months, fillers 6–18 months depending on type). Disclose duration.

Unsubstantiated superiority: "Better than [competitor]" without comparative clinical data.

Implied medical benefits: "Rejuvenates," "reverses aging," or "anti-aging" can imply drug-like claims if not carefully contextualized as cosmetic improvement.

Testimonial misuse: Patient reviews stating "I look 10 years younger" without disclosure that results are exceptional, not typical.

Hidden material conditions: Showing results after 3 treatments but implying single-treatment efficacy. Disclose the treatment regimen.

Fake reviews: Posting fabricated patient testimonials or paying for fake reviews. The FTC has aggressively pursued this; penalties include civil fines and corrective advertising.

Endorsement non-disclosure: Staff or influencer posts without #ad or material-connection disclosure.

Document everything. Maintain a file for each claim: the clinical study, FDA clearance letter, manufacturer data sheet, or peer-reviewed publication. If the FTC or FDA asks, you must produce it within days.

Use manufacturer language. Leverage the FDA-cleared indication from the device or product labeling. If the 510(k) summary says "reduces the appearance of moderate to severe glabellar lines," use that language or a close paraphrase.

Disclose material conditions. State the number of treatments, maintenance schedule, concurrent products, and timeline for results in the same prominence as the claim.

Train your team. Social media posts by staff are your responsibility. Provide templates and guidelines; audit regularly. A single nurse injector's Instagram post claiming "permanent results" can trigger an FTC investigation of your entire practice.

Avoid superlatives without data. "The best," "the only," "revolutionary"—these require substantiation. Safer: "Clinically proven to reduce wrinkles" (if true) or "FDA-cleared for skin tightening."

Before/after protocol: Establish a standard for lighting, angle, timing, and disclosure. Have a photographer or use consistent phone settings. Require patient consent and disclosure language on every image.